Clinical Trial

Managed Access Programs for EXV811, Atrasentan

Name: Managed Access Programs for EXV811, Atrasentan — clinical trial record (NCT07319585)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Available

View on ClinicalTrials.gov →

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to EXV811, Atrasentan

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-18.

Status change: Temporarily Not Available → Available 2026-01-20

Trial Details

NCT Number	NCT07319585
Lead Sponsor	Novartis Pharmaceuticals
Conditions	IgA Nephropathy
Updated on ClinicalTrials.gov	2026-01-22